Because cytokine release syndrome is a leading cause of COVID-19 deaths, we speculate that increased interleukin-6 (IL-6) production in children with Down syndrome (25) could increase risk for death and that elevated IL-6 results from altered immune response to viral infection in patients with Down syndrome, as noted with influenza (26). This evidence concerns the gene IL6 and viral infectious disease.